Add ANI As A Trusted Source For Reliable Information
Search For "metastatic hormone sensitive prostate cancer"
Updated : 7 years ago IST
Washington D.C. [USA], June 2 (ANI): A new study reveals that Enzalutamide, an oral androgen receptor inhibitor can yield better outcomes and increase survival for men with metastatic hormone-sensitive prostate cancer (mHSPC).